GST, DILI, biomarker
Showing 1 - 25 of 3,511
Drug-induced Liver Injury Trial in Beijing
Recruiting
- Drug-induced Liver Injury
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Aug 27, 2022
Drug-Induced Liver Injury, Cholestatic Liver Injury, Mixed Liver Injury Trial in Shanghai (MT2004 Capsule, MT2004 Capsule
Recruiting
- Drug-Induced Liver Injury
- +2 more
- MT2004 Capsule
- MT2004 Capsule Placebo
-
Shanghai, Shanghai, ChinaShanghai Jiaotong University School of Medicine,Renji Hospital
Aug 25, 2023
Tuberculosis, Drug Induced Liver Injury, Hepatitis Trial in Bangkok (N acetyl cysteine)
Recruiting
- Tuberculosis
- +2 more
- N acetyl cysteine
-
Bangkok, ThailandFaculty of Medicine, Siriraj Hospital
Feb 12, 2023
Anorexia Nervosa, Atypical Anorexia Nervosa (Other Specified Eating Disorder), Bulimia Nervosa Trial (GST, CBT-E)
Not yet recruiting
- Anorexia Nervosa
- +3 more
- GST
- CBT-E
- (no location specified)
Apr 13, 2023
Healthy Participant Trial in Changchun (GST-HG171/Ritonavir, Itraconazole)
Completed
- Healthy Participant
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 11, 2023
COVID-19 Pneumonia Trial in Changchun (GST-HG171 Tablets)
Recruiting
- COVID-19 Pneumonia
- GST-HG171 Tablets
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 26, 2023
COVID-19 Pneumonia Trial in Changchun (GST-HG171 Tablets)
Completed
- COVID-19 Pneumonia
- GST-HG171 Tablets
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 26, 2023
COVID-19 Respiratory Infection Trial in Changchun (GST-HG171/ritonavir, ritonavir)
Active, not recruiting
- COVID-19 Respiratory Infection
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 10, 2023
COVID-19 Trial in Changchun (GST-HG171, of GST-HG171)
Recruiting
- COVID-19
- GST-HG171
- placebo of GST-HG171
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Dec 25, 2022
COVID-19 Pneumonia Trial (GST-HG171/Ritonavir, Placebo)
Not yet recruiting
- COVID-19 Pneumonia
- GST-HG171/Ritonavir
- Placebo
- (no location specified)
Dec 18, 2022
Chronic Hepatitis b Trial in Changchun (GST-HG141)
Recruiting
- Chronic Hepatitis b
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Dec 5, 2022
Healthy Volunteers Trial in Fujian (GST-HG151, Placebo)
Recruiting
- Healthy Volunteers
- GST-HG151
- Placebo
-
Fujian, Fuzhou, ChinaMengchao Hepatpbiliary Hospital of Fujian Medical University
Apr 19, 2022
Hepatitis B Trial in Changchun (GST-HG141 tablets, Matching Placebos for GST-HG141 tablets)
Completed
- Hepatitis B
- GST-HG141 tablets
- Matching Placebos for GST-HG141 tablets
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Jun 6, 2022
Cluster C Personality Disorder (Diagnosis), Mother-Child Relations Trial (Group schematherapy)
Not yet recruiting
- Cluster C Personality Disorder (Diagnosis)
- Mother-Child Relations
- Group schematherapy
- (no location specified)
Oct 21, 2023
Stroke, Acute Trial in France (Blood Samples)
Recruiting
- Stroke, Acute
- Blood Samples
-
Bar-le-Duc, France
- +4 more
Jun 27, 2022
Fatty Liver Trial in Naples
Completed
- Fatty Liver
-
Naples, ItalyUniversity of Campania Luigi Vanvitelli
Mar 27, 2023
Pharmacokinetics, Food Affect, Single Ascending Dose Trial in Changchun (GST-HG121 tablets, Placebo)
Recruiting
- Pharmacokinetics
- +3 more
- GST-HG121 tablets
- Placebo
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Dec 26, 2022
Susceptibility Genes for APAP Induced Drug Induced LIver Injury
Recruiting
- Acetaminophen
- +3 more
- genetic polymorphism
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jul 14, 2021
Drug-induced Liver Injury, Gut Microbiota, Biochemical Markers Trial in Wuhan (Collect stool and blood samples from patients)
Recruiting
- Drug-induced Liver Injury
- +2 more
- Collect stool and blood samples from patients
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Jul 20, 2022
Drug-induced Liver Injury,Chronic Trial in Beijing (36 Weeks Methylprednisolone, 48 weeks Methylprednisolone)
Active, not recruiting
- Drug-induced Liver Injury,Chronic
- 36 Weeks Methylprednisolone
- 48 weeks Methylprednisolone
-
Beijing, ChinaBeijing 302 hospital
Sep 3, 2021
PreDiabetes Trial in Singapore (Single dose of 75 grams glucose in 200ml water)
Not yet recruiting
- PreDiabetes
- Single dose of 75 grams glucose in 200ml water
-
Singapore, SingaporeHuman Development Research Centre, SICS, A*STAR
Nov 6, 2023
Blood Based Biomarkers in Primary Care Setting for Alzheimer's
Enrolling by invitation
- Mild Cognitive Impairment
- PrecivityAD
-
Indianapolis, IndianaIndiana University Health Physicians Primary Care
Apr 25, 2023
MiRNA in Detecting Active Germ Cell Tumors in Early Suspected
Recruiting
- Malignant Testicular Germ Cell Tumor
- Non-Interventional Study
-
Los Angeles, California
- +1 more
Sep 28, 2023
Post Concussive Symptoms Trial (Early intervention programme, Enhanced usual care)
Active, not recruiting
- Post Concussive Symptoms
- Early intervention programme
- Enhanced usual care
- (no location specified)
Apr 11, 2023
Meningioma Trial in Heidelberg (Explorative biomarker study)
Not yet recruiting
- Meningioma
- Explorative biomarker study
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Oct 23, 2023